Healthcare Sector

ONCY

Market Tracker

$0.99
-0.02
(-2.05%)
8:20 am
Next Earnings: (est.) n/a
  • ONCY (Selected)

    Oncolytics Biotech Inc.

ONCY Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

ONCY Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

ONCY Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

ONCY Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

ONCY News

  • Oncolytics Biotech® Reports Second Quarter Financial Results and Details Clinical Program Plans for Pelareorep

    08/08 09:05 am

    Benzinga

    Read more
  • Biotech Underdogs Line Up for Pivotal Shots at Game-Changing Cancer Treatments

    07/29 03:46 pm

    Benzinga

    Read more
  • High‑Growth Oncology Market Projected For US$900bn in Revenue Despite Policy Headwinds

    07/23 09:26 am

    Benzinga

    Read more
  • Cancer Pipeline Milestones Coming Fast as Regulators Revisit Research Priorities

    07/16 06:51 pm

    Benzinga

    Read more
  • Oncolytics Biotech® Presents Aggregated Translational Data Providing Evidence of Pelareorep's Effectiveness Across Multiple Tumor Types

    07/16 08:30 am

    Benzinga

    Read more
  • The $900 Billion Question: Who Will Deliver the Next Cancer Breakthrough?

    06/26 11:44 am

    Benzinga

    Read more
  • New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer Biotechs

    05/23 09:10 am

    Benzinga

    Read more
  • Oncolytics Biotech® Reports First Quarter Financial Results and Highlights Clinical Momentum

    05/14 04:01 pm

    Benzinga

    Read more
  • Oncolytics Biotech® to Host Conference Call to Discuss First Quarter Financial Results and Recent Operational Highlights

    05/06 07:00 am

    Benzinga

    Read more
  • New Cancer Treatments Spark Hope as Traditional Funding Faces Uncertainty

    05/01 11:01 am

    Benzinga

    Read more
  • Why the Global Cancer Market Could Surpass $900 Billion--And the Stocks Leading the Charge

    03/08 08:33 am

    Benzinga

    Read more
  • Oncology Breakthroughs: How Cancer Research Is Advancing in 2025

    02/27 11:04 am

    Benzinga

    Read more
  • Investors Eye Biotech Sector as Cancer Therapy Market Surges

    02/19 11:06 am

    Benzinga

    Read more
  • Cutting-Edge Cancer Therapies Lead the Way into a Transformative Year

    01/15 11:10 am

    Benzinga

    Read more
  • Regulatory Approval Clears Path for Oncolytics Biotech® to Advance Promising Pancreatic Cancer Treatment, Following a Review of Safety Data

    01/15 08:02 am

    Benzinga

    Read more
  • Oncology in Focus: How Emerging Therapies Are Reshaping Cancer Treatment

    12/26 12:26 pm

    Benzinga

    Read more
  • Biotech Advances Drive Cancer Research as Global Rates Continue Upward Trend

    12/02 11:18 am

    Benzinga

    Read more
  • Optimism Grows in the Fight Against Cancer as Breakthroughs and Funding Increase

    09/24 09:15 am

    Benzinga

    Read more
  • Cancer Research Sees Major Boost as New Breakthroughs Emerge from Key Oncology Players

    09/19 12:08 pm

    Benzinga

    Read more
  • Oncolytics Biotech (ONCY) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

    06/04 09:55 am

    Zacks Investment Research

    Read more
  • Gilead (GILD) Gears Up to Report Q1 Earnings: What to Expect?

    04/22 01:57 pm

    Zacks Investment Research

    Read more
  • Bristol-Myers' (BMY) to Report Q1 Earnings: What You Should Know

    04/22 01:56 pm

    Zacks Investment Research

    Read more
  • Novartis (NVS) to Report Q1 Earnings: What to Expect?

    04/19 10:10 am

    Zacks Investment Research

    Read more
  • After Plunging -29.54% in 4 Weeks, Here's Why the Trend Might Reverse for Oncolytics Biotech Inc. (ONCY)

    08/17 09:35 am

    Zacks Investment Research

    Read more
  • 5 Analysts Have This to Say About Oncolytics Biotech

    06/29 03:00 pm

    Benzinga

    Read more
  • Tesla, Anheuser-Busch, Logitech stocks rise, AMC, iRobot, Virgin Galactic shares fall, and other stocks on the move

    06/22 03:38 pm

    MarketWatch

    Read more
  • Why Avid Bioservices Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

    06/22 01:09 pm

    Benzinga

    Read more
  • Expert Ratings for Oncolytics Biotech

    05/26 05:01 pm

    Benzinga

    Read more
  • Why Hibbett Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

    05/26 12:48 pm

    Benzinga

    Read more
  • Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2023

    05/24 11:00 am

    Benzinga

    Read more
  • New Strong Buy Stocks for January 18th

    01/18 09:12 am

    Zacks Investment Research

    Read more
  • Is DICE Therapeutics (DICE) Stock Outpacing Its Medical Peers This Year?

    12/16 10:40 am

    Zacks Investment Research

    Read more
  • 2 Sector ETFs Hovering Around a 52-Week High

    12/06 02:00 pm

    Zacks Investment Research

    Read more
  • What Makes Oncolytics Biotech Inc. (ONCY) a Strong Momentum Stock: Buy Now?

    12/05 01:00 pm

    Zacks Investment Research

    Read more
  • Oncolytics (ONCY) Up on Lead Drug Securing 2nd FDA Fast Track Tag

    12/02 11:59 am

    Zacks Investment Research

    Read more
  • Oncolytics Biotech Inc. (ONCY) Hit a 52 Week High, Can the Run Continue?

    12/02 10:15 am

    Zacks Investment Research

    Read more
  • Why Dollar General Shares Are Trading Lower By Over 8%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session

    12/01 02:33 pm

    Benzinga

    Read more
  • Nasdaq Turns Lower; Dow Tumbles Over 300 Points

    12/01 01:09 pm

    Benzinga

    Read more
  • Oncolytics Biotech Inc. (ONCY) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

    11/18 10:55 am

    Zacks Investment Research

    Read more
  • Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday

    11/09 06:08 am

    Benzinga

    Read more
  • 5 Penny Stocks To Buy According To Analysts, Targets Up To 995%

    11/08 03:21 pm

    PennyStocks

    Read more
  • Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday

    11/08 06:00 am

    Benzinga

    Read more
  • Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2022

    10/06 10:25 am

    Benzinga

    Read more
  • Ride on Rising P/E Investing With These 5 Top-Ranked Stocks

    07/08 07:52 am

    Zacks Investment Research

    Read more
  • The Daily Biotech Pulse: NuCana Shelves Biliary Tract Cancer Study, Tricida Data Readout Pushed Back Due to Ukrainian Crisis, Synlogic Names New CFO

    03/03 08:46 am

    Benzinga

    Read more
  • The Daily Biotech Pulse: LogicBio Genome Editing Therapy Study Placed On Clinical Hold, Gilead Q4 Disappoints On Slowing Veklury Sales

    02/02 08:33 am

    Benzinga

    Read more
  • The Daily Biotech Pulse: Galapagos Appoints J&J Exec As CEO, Aridis Gets Funding For Antiviral Treatment, Moderna Starts Omicron-Specific Booster Study

    01/27 08:57 am

    Benzinga

    Read more
  • 4 Penny Stocks To Buy For Under $4 Right Now

    01/19 01:22 pm

    PennyStocks

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: